Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections
Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections
Not yet recruiting · NCT05750589 · Registry updated 2026-04-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections | eye disorder, retinal disorder | Not yet recruiting | Phase 3 | 2026-04-03 | NCT05750589 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| iRenix Medical, Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| R. Gary Lane, II MD | San Antonio | United States | 1 |